There are a number of errors in Table 3. Multiple upper-case T’s were included instead of the correct lower-case, italicized t’s. Trans-vaccenic acid was incorrectly spelled as Transvaccenic acid, and Palmitelaidic acid was incorrectly written as Palmitoleic acid. Please see the correct Table 3 here.
Table 3. Range, mean and percentiles of FA concentrations (μmol/L) of plasma total lipids.
| Fatty Acid | Min | Mean±SD | Max | 10 | 25 | 50 | 75 | 90 |
|---|---|---|---|---|---|---|---|---|
| 14:0 (Myristic acid) | 16.2 | 63.6 ± 37.1 | 325.7 | 29.8 | 39.2 | 54.0 | 76.2 | 104.7 |
| 15:0 (Pentadyclic acid) | t | 17.8 ± 6.7 | 56.1 | 10.8 | 13.2 | 17.1 | 21.3 | 26.3 |
| 16:0 (Palmitic acid) | 285.4 | 1631.1 ± 459.3 | 4064.5 | 1140.2 | 1339.7 | 1569.5 | 1839.2 | 2182.2 |
| 18:0 (Stearic acid) | 110.2 | 489.5 ± 124.3 | 1013.7 | 353.3 | 406.9 | 474.2 | 556.8 | 650.9 |
| 19:0 | t | 4.3 ± 4.2 | 25.7 | t | 1.1 | 3.1 | 6.6 | 10.2 |
| 20:0 (Arachidic acid) | t | 4.9 ± 3.7 | 29.8 | t | 2.6 | 4.6 | 6.4 | 9.4 |
| 21:0 | t | 1.5 ± 1.9 | 10.0 | t | t | 0.3 | 2.9 | 4.1 |
| 22:0 (Behenic acid) | t | 6.7 ± 5.3 | 39.0 | t | 3.4 | 6.0 | 9.4 | 14.0 |
| 24:0 (Lignoceric acid) | t | 1.4 ± 2.4 | 15.7 | t | t | t | 2.4 | 5.1 |
| 14:1 (Myristoleic acid) | t | 2.7 ± 4.1 | 31.3 | t | t | t | 4.2 | 7.7 |
| 15:1 c10 | t | 0.1 ± 0.3 | 2.7 | t | t | t | t | t |
| 16:1 c9 (Palmitoleic acid) | 27.7 | 133.0 ± 67.2 | 555.9 | 67.8 | 88.5 | 119.5 | 156.9 | 211.4 |
| 17:1 c10 | t | 10.5 ± 7.4 | 45.2 | t | 6.2 | 10.7 | 14.7 | 19.1 |
| 18:1 c9 (Oleic acid) | 178.7 | 1285.5± 416.7 | 3210.5 | 858.6 | 1007.1 | 1226.3 | 1472.0 | 1808.7 |
| 18:1 c11 (Vaccenic acid) | 11.4 | 129.2 ± 59.5 | 562.9 | 81.5 | 96.6 | 114.3 | 141.5 | 185.1 |
| 18:1 c12 | t | 18.7 ± 13.6 | 101.8 | 6.6 | 9.0 | 14.9 | 22.7 | 38.3 |
| 18:1 c13 | t | 3.5 ± 3.5 | 18.1 | t | 1.2 | 2.5 | 4.5 | 8.9 |
| 18:1 c14 | t | 2.2 ± 1.9 | 11.6 | t | 0.6 | 2.0 | 3.4 | 5.0 |
| 19:1 c10 | t | 0.5 ± 1.1 | 8.2 | t | t | t | t | 1.9 |
| 20:1 c5 | t | 4.8 ± 3.1 | 26.9 | 2.2 | 3.1 | 4.2 | 5.6 | 7.6 |
| 20:1 c8 | t | 1.3 ± 1.8 | 10.5 | t | t | 0.4 | 2.1 | 4.1 |
| 20:1 c11 (Gondoic acid) | t | 8.2 ± 4.9 | 29.5 | 2.2 | 4.8 | 8.0 | 11.1 | 14.1 |
| 22:1 c13 (Erucic acid) | t | 3.9 ± 5.9 | 48.0 | t | t | t | 7.1 | 12.2 |
| 24:1 c15 (Nervonic acid) | t | 4.0 ± 5.3 | 30.0 | t | t | 1.8 | 6.3 | 11.8 |
| 16:1 t9 (Palmitelaidic acid) | t | 17.0 ± 9.1 | 65.2 | t | 12.1 | 17.3 | 22.0 | 28.2 |
| 18:1 t4 | t | 5.2 ± 5.3 | 30.7 | t | t | 4.1 | 8.3 | 12.3 |
| 18:1 t5 (Thalictric acid) | t | 1.7 ± 2.9 | 19.0 | t | t | 0.5 | 1.7 | 5.6 |
| 18:1 t6-8 (Petroselaidic acid) | t | 7.5 ±5.9 | 56.0 | 2.5 | 3.8 | 5.7 | 9.5 | 14.8 |
| 18:1 t9 (Elaidic acid) | t | 16.5 ± 11.3 | 88.0 | 6.4 | 9.0 | 13.1 | 20.0 | 32.9 |
| 18:1 t10 | t | 17.0 ± 11.3 | 71.1 | 6.4 | 8.8 | 13.7 | 21.8 | 32.4 |
| 18:1 t11 (Trans-vaccenic acid) | t | 14.0 ± 8.1 | 74.2 | 5.9 | 8.7 | 12.3 | 18.0 | 24.7 |
| 18:1 t12 | t | 9.6 ± 5.7 | 42.8 | 4.0 | 5.6 | 8.4 | 12.3 | 17.1 |
| 18:1 t13 or c6 | t | 12.5 ± 17.1 | 175.7 | t | 5.7 | 9.3 | 13.9 | 21.1 |
| 18:2 tt | t | 3.5 ± 4.3 | 38.7 | t | 1.1 | 2.3 | 4.5 | 7.4 |
| 18:2 t9t12 (Linoelaidic acid) | t | 2.1 ± 3.0 | 20.9 | t | t | 1.2 | 2.5 | 6.7 |
| 18:2 c9t13 | t | 8.5 ± 8.0 | 69.3 | t | 2.1 | 7.7 | 11.9 | 17.7 |
| 18:2 c9t12 | t | 15.4 ± 6.4 | 45.2 | 8.4 | 10.9 | 14.2 | 18.9 | 24.0 |
| 18:2 t9c12 | t | 9.8 ± 4.3 | 31.5 | 5.3 | 6.9 | 9.0 | 12.2 | 15.6 |
| 18:2 c9c14 | t | 3.0 ± 7.7 | 62.1 | t | t | t | t | 10.0 |
| 18:2 c9c15 (Mangiferic acid) | t | 3.0 ± 3.9 | 39.1 | t | t | 2.0 | 4.6 | 7.2 |
| 18:2 c9t11 CLA | t | 14.4 ± 6.2 | 42.7 | 7.5 | 10.1 | 13.3 | 17.3 | 22.4 |
| 18:2 c11t13 CLA | t | 2.1 ± 1.8 | 12.3 | t | t | 2.2 | 3.0 | 4.2 |
| 18:2 t10c12 CLA | t | 4.3 ± 2.5 | 17.9 | 2.0 | 2.9 | 3.8 | 5.2 | 7.3 |
| 18:2 c/c CLA1 | t | 0.8 ± 1.3 | 8.5 | t | t | t | 1.4 | 2.6 |
| 18:2 c/c CLA2 | t | 0.5 ± 1.0 | 6.6 | t | t | t | t | 1.9 |
| 18:2 tt CLA | t | 6.5 ± 4.4 | 23.2 | t | 3.2 | 6.5 | 9.5 | 11.9 |
| 18:2 c9c12 (LA) | 279.7 | 2233.8± 622.6 | 4970.5 | 1540.1 | 1853.0 | 2208.2 | 2596.0 | 2962.0 |
| 18:3 c6c9c12 (γ-linolenic acid) | 1.4 | 23.5 ± 13.8 | 93.3 | 9.0 | 13.8 | 20.8 | 29.4 | 41.4 |
| 20:2 c11c14 (Dihomo linolenic acid) | t | 13.1 ± 5.0 | 37.3 | 7.8 | 9.8 | 12.5 | 16.0 | 19.7 |
| 20:3 c8c11c14 (Homo-γ-linolenic acid) | 7.9 | 74.3 ± 30.4 | 222.1 | 41.5 | 53.0 | 68.2 | 90.4 | 113.4 |
| 20:4 c5c8c11c14 (AA) | 42.7 | 393.0 ± 119.1 | 882.8 | 254.8 | 313.3 | 385.6 | 461.4 | 548.2 |
| 22:2 c13c16 (Docosadienoic acid) | t | 3.1 ± 3.3 | 18.4 | t | t | 2.8 | 4.9 | 7.3 |
| 22:4 c7c10c13c16 (Adrenic acid) | t | 15.4 ± 23.0 | 158.4 | 1.9 | 5.6 | 8.5 | 12.5 | 36.5 |
| 22:5 c4c7c10c13c16 (n-6 DPA) | t | 8.0 ± 5.9 | 41.1 | t | 4.7 | 7.4 | 10.3 | 15.1 |
| 18:3 c9c12c15 (LNA) | 12.0 | 54.4 ± 25.1 | 186.9 | 29.1 | 37.9 | 48.6 | 65.4 | 87.6 |
| 18:4 c6c9c12c15 (Stearidonic acid) | t | 0.2 ± 0.5 | 4.3 | t | t | t | t | 0.6 |
| 20:3 c11c14c17 (Dihomolinoleic acid) | t | 1.6 ± 2.5 | 17.9 | t | t | t | 2.9 | 4.8 |
| 20:5 c5c8c11c14c17 (EPA) | 4.4 | 40.3 ± 28.3 | 215.4 | 16.0 | 23.4 | 32.4 | 47.5 | 73.3 |
| 22:3 c13c16c19 | t | 0.6 ± 1.9 | 15.1 | t | t | t | t | 2.6 |
| 22:5 c7c10c13c16c19 (n-3 DPA) | t | 23.9 ± 10.0 | 88.5 | 14.0 | 17.7 | 22.1 | 27.8 | 36.5 |
| 22:6 c4c7c10c13c16c19 (DHA) | 7.2 | 88.8 ± 36.8 | 237.5 | 47.8 | 62.7 | 82.0 | 110.6 | 138.0 |
| Total FA | 1251.1 | 6947.6±1816.2 | 16225.3 | 5052.5 | 5780.4 | 6745.4 | 7947.8 | 9108.9 |
QALY: Quality-adjusted life years; CHD: Coronary heart disease; CKD: Chronic kidney disease; OI: Opportunistic infection; AE: Adverse event; VL: Viral load.
Reference
- 1. Abdelmagid SA, Clarke SE, Nielsen DE, Badawi A, El-Sohemy A, Mutch DM (2015) Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults. PLoS ONE 10(2): e0116195 doi:10.1371/journal.pone.0116195 [DOI] [PMC free article] [PubMed] [Google Scholar]